Century Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Century Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2020 to Q2 2024.
  • Century Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $28.6M, a 14.3% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $28.6M +$3.58M +14.3% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $19.3M -$8.89M -31.5% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $20.4M -$8.57M -29.6% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 $24.6M -$4.94M -16.7% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $25M +$265K +1.07% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $28.2M +$16.5M +142% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $28.9M +$17.1M +144% Dec 31, 2022 10-K 2024-03-14
Q3 2022 $29.5M +$17.5M +145% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $24.7M +$12.5M +102% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $11.7M Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $11.9M +$2.46M +26.2% Dec 31, 2021 10-K 2023-03-16
Q3 2021 $12M Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $12.3M Jun 30, 2021 10-Q 2021-08-12
Q4 2020 $9.39M Dec 31, 2020 10-K 2022-03-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.